Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Bioarctic, Chance, Eisai, Kelun-Biotech, Lanexa, Mezzion, Norgine, Rznomics, Specialised, Sunshine Lake, Ultragreen.ai.